Effects of gonadotrophin-releasing hormone agonist on uterine fibroids and bone density. 1989

G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
Institute E. Bruzzone, Rheumatological Centre, University of Genoa, Italy.

Bone density (BD) was evaluated by single photon absorptiometry (SPA) in 18 women treated with Buserelin a gonadotrophin-releasing hormone (LHRH) analogue, for uterine fibroids. Buserelin was administered for a period of 6 mth. Amenorrhoea and oestradiol levels in the follicular-phase range were recorded in all patients during treatment. Fibroid volume was evaluated by means of ultrasound. SPA was performed at the 1/3 proximal radius and at the 1/10 distal radius sites before starting therapy and every 2 mth subsequently for 12 mth. BD was also measured in a control group of 18 normally-menstruating premenopausal women, matched for age and body mass index. No significant changes in BD at the proximal or distal radius sites were observed in either the cases or the controls during the study. Moreover, comparison of the data on the cases and the controls revealed no differences in BD at 0, 6 or 12 mth. Thus, although LHRH analogue treatment proved effective in reducing fibroids, it did not cause any significant changes in BD.

UI MeSH Term Description Entries
D007889 Leiomyoma A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues. Fibroid,Fibroid Tumor,Fibroid Uterus,Fibroids, Uterine,Fibroma, Uterine,Fibromyoma,Leiomyoma, Uterine,Fibroid Tumors,Fibroid, Uterine,Fibroids,Fibromas, Uterine,Fibromyomas,Leiomyomas,Tumor, Fibroid,Tumors, Fibroid,Uterine Fibroid,Uterine Fibroids,Uterine Fibroma,Uterine Fibromas,Uterus, Fibroid
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002064 Buserelin A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications. Bigonist,Buserelin Acetate,HOE-766,Profact,Receptal,Suprecur,Suprefact,Tiloryth,Acetate, Buserelin,HOE 766,HOE766
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral

Related Publications

G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
May 1994, British journal of obstetrics and gynaecology,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
June 1998, Bailliere's clinical obstetrics and gynaecology,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
March 1988, Fertility and sterility,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
July 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
March 2014, Obstetrics & gynecology science,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
February 2017, Zhonghua fu chan ke za zhi,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
January 2003, The Cochrane database of systematic reviews,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
January 1992, Clinical therapeutics,
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
March 1993, Human reproduction (Oxford, England),
G Bianchi, and S Costantini, and P Anserini, and G Rovetta, and P Monteforte, and M V Menada, and L Fagà, and L De Cecco
November 1996, The Australian & New Zealand journal of obstetrics & gynaecology,
Copied contents to your clipboard!